MDL Panel Combines Diabetes Drug Cancer Suits
The U.S. Judicial Panel on Multidistrict Litigation on Monday unified 53 suits over diabetes drugs marketed by Merck & Co. Inc., Novo Nordisk Inc., Eli Lilly & Co. and a Bristol-Myers...To view the full article, register now.
Already a subscriber? Click here to view full article